Literature DB >> 25177261

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014.

Cornelia Liedtke1, Marc Thill2, Volker Hanf3, Florian Schütz4.   

Abstract

Entities:  

Keywords:  Adjuvant treatment; Breast cancer; Surgery; Treatment recommendations

Year:  2014        PMID： 25177261      PMCID： PMC4132219          DOI： 10.1159/000363591

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  100 in total

1.  Outcome of a phase II prospective study on partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy.

Authors:  Cynthia Aristei; Isabella Palumbo; Giorgia Capezzali; Alessia Farneti; Vittorio Bini; Lorenzo Falcinelli; Manuela Margaritelli; Valentina Lancellotta; Claudio Zucchetti; Elisabetta Perrucci
Journal:  Radiother Oncol       Date:  2013-09-14       Impact factor: 6.280

2.  Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.

Authors:  Jennifer F De Los Santos; Alan Cantor; Keith D Amos; Andres Forero; Mehra Golshan; Janet K Horton; Clifford A Hudis; Nola M Hylton; Kandace McGuire; Funda Meric-Bernstam; Ingrid M Meszoely; Rita Nanda; E Shelley Hwang
Journal:  Cancer       Date:  2013-02-21       Impact factor: 6.860

3.  Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy.

Authors:  Ivo A Olivotto; Timothy J Whelan; Sameer Parpia; Do-Hoon Kim; Tanya Berrang; Pauline T Truong; Iwa Kong; Brandy Cochrane; Alan Nichol; Isabelle Roy; Isabelle Germain; Mohamed Akra; Melanie Reed; Anthony Fyles; Theresa Trotter; Francisco Perera; Wayne Beckham; Mark N Levine; Jim A Julian
Journal:  J Clin Oncol       Date:  2013-07-08       Impact factor: 44.544

4.  An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence.

Authors:  Nehmat Houssami; Robin Turner; Petra Macaskill; Lindsay W Turnbull; David R McCready; Todd M Tuttle; Neha Vapiwala; Lawrence J Solin
Journal:  J Clin Oncol       Date:  2014-01-06       Impact factor: 44.544

5.  Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer.

Authors:  Edith A Perez; Vera J Suman; Nancy E Davidson; Julie R Gralow; Peter A Kaufman; Daniel W Visscher; Beiyun Chen; James N Ingle; Shaker R Dakhil; Joanne Zujewski; Alvaro Moreno-Aspitia; Thomas M Pisansky; Robert B Jenkins
Journal:  J Clin Oncol       Date:  2011-10-31       Impact factor: 44.544

6.  Diet and cancer prevention: Contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Authors:  Carlos A Gonzalez; Elio Riboli
Journal:  Eur J Cancer       Date:  2010-09       Impact factor: 9.162

7.  Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer.

Authors:  Sylvia Adams; Lina Kozhaya; Frank Martiniuk; Tze-Chiang Meng; Luis Chiriboga; Leonard Liebes; Tsivia Hochman; Nicholas Shuman; Deborah Axelrod; James Speyer; Yelena Novik; Amy Tiersten; Judith D Goldberg; Silvia C Formenti; Nina Bhardwaj; Derya Unutmaz; Sandra Demaria
Journal:  Clin Cancer Res       Date:  2012-07-05       Impact factor: 12.531

8.  Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.

Authors:  Judy C Boughey; Vera J Suman; Elizabeth A Mittendorf; Gretchen M Ahrendt; Lee G Wilke; Bret Taback; A Marilyn Leitch; Henry M Kuerer; Monet Bowling; Teresa S Flippo-Morton; David R Byrd; David W Ollila; Thomas B Julian; Sarah A McLaughlin; Linda McCall; W Fraser Symmans; Huong T Le-Petross; Bruce G Haffty; Thomas A Buchholz; Heidi Nelson; Kelly K Hunt
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

9.  Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.

Authors:  Sandra M Swain; Gong Tang; Charles E Geyer; Priya Rastogi; James N Atkins; Paul P Donnellan; Louis Fehrenbacher; Catherine A Azar; André Robidoux; Jonathan A Polikoff; Adam M Brufsky; David D Biggs; Edward A Levine; John L Zapas; Louise Provencher; Donald W Northfelt; Soonmyung Paik; Joseph P Costantino; Eleftherios P Mamounas; Norman Wolmark
Journal:  J Clin Oncol       Date:  2013-08-12       Impact factor: 44.544

10.  Feasibility of Performing Total Skin-Sparing Mastectomy in Patients With Prior Circumareolar Mastopexy or Reduction Mammoplasty Incisions.

Authors:  Carolyn J Vaughn; Anne Warren Peled; Laura J Esserman; Robert D Foster
Journal:  Ann Plast Surg       Date:  2013-06-19       Impact factor: 1.539
View more
  4 in total

1.  Romancing the Boost - the Higher, the Better?

Authors:  Felix Sedlmayer; Marie-Luise Sautter-Bihl; Rolf Sauer
Journal:  Breast Care (Basel)       Date:  2015-08-19       Impact factor: 2.860

Review 2.  St. Gallen/Vienna 2015: A Brief Summary of the Consensus Discussion.

Authors:  Michael Gnant; Christoph Thomssen; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2015-04       Impact factor: 2.860

Review 3.  The Right Treatment for the Right Patient - Personalised Treatment of Breast Cancer.

Authors:  A Scharl; T Kühn; T Papathemelis; A Salterberg
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-07       Impact factor: 2.915

Review 4.  Targeted Therapies in HER2-Positive Breast Cancer - a Systematic Review.

Authors:  Amelie Schramm; Nikolaus De Gregorio; Peter Widschwendter; Visnja Fink; Jens Huober
Journal:  Breast Care (Basel)       Date:  2015-06-18       Impact factor: 2.860
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.